标题
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
作者
关键词
-
出版物
Nature Nanotechnology
Volume 12, Issue 8, Pages 813-820
出版商
Springer Nature
发表日期
2017-04-17
DOI
10.1038/nnano.2017.57
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy
- (2016) Jayoung Kim et al. Acta Biomaterialia
- Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain
- (2016) Xiaowei Li et al. BIOMATERIALS
- Gene Therapy: The View from NCATS
- (2016) Philip J. Brooks et al. HUMAN GENE THERAPY
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
- (2016) Partow Kebriaei et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
- (2016) R Monjezi et al. LEUKEMIA
- Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform
- (2016) Chiara F. Magnani et al. Oncotarget
- Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
- (2015) Antonella Mangraviti et al. ACS Nano
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Synthetic biology approaches to engineer T cells
- (2015) Chia-Yung Wu et al. CURRENT OPINION IN IMMUNOLOGY
- CAR therapy: the CD19 paradigm
- (2015) Michel Sadelain JOURNAL OF CLINICAL INVESTIGATION
- Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor
- (2015) Xiuyan Wang et al. JOURNAL OF IMMUNOTHERAPY
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer
- (2015) Karoline B Kuchenbaecker et al. NATURE GENETICS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Minicircle DNA vectors for gene therapy: advances and applications
- (2014) Vítor Gaspar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
- (2014) Daniel Abate-Daga et al. HUMAN GENE THERAPY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
- (2013) Marco L. Davila et al. PLoS One
- Mimicking cellular transport mechanism in stem cells through endosomal escape of new peptide-coated quantum dots
- (2013) Karthikeyan Narayanan et al. Scientific Reports
- Evaluation of Long-term Transgene Expression in piggyBac-Modified Human T Lymphocytes
- (2012) Yozo Nakazawa et al. JOURNAL OF IMMUNOTHERAPY
- A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA Transposon
- (2012) Erin R Burnight et al. Molecular Therapy-Nucleic Acids
- Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
- (2011) Steven A. Rosenberg Nature Reviews Clinical Oncology
- Monitoring the Efficacy of Adoptively Transferred Prostate Cancer-Targeted Human T Lymphocytes with PET and Bioluminescence Imaging
- (2008) K. Dobrenkov et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More